Organogenesis Holdings Inc Class A (ORGO)
EBITDA Growth
-755.24%
Quarterly · Period ending:
ORGO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-755.24%period ending
Latest reported-755.24%period ending
ORGO Quarterly EBITDA YoY % (-1306.10% → -755.24%)
Year-over-year change
High-resolution chart · PNG
ORGO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -755.2423% | |
| -187.7077% | |
| 324.0308% | |
| 163.1053% | |
| 46.7181% | |
| -13,641.6667% | |
| 51.0182% | |
| -9.752% | |
| -173.4694% | |
| 366.6667% | |
| -17.1624% | |
| 165.7848% | |
| -9.7729% | |
| -102.2158% | |
| -47.4411% | |
| -76.6419% | |
| -46.3758% | |
| -84.764% | |
| 4.5823% | |
| -27.047% | |
| 5,358.4615% | |
| 232.7496% | |
| 3,926.3333% | |
| 540.2523% | |
| 89.7658% | |
| -5.3971% | |
| 101.2519% | |
| -164.3412% | |
| -439.0827% | |
| -886.5191% | |
| -9,521.5598% | |
| 21.1748% | |
| -324.9292% | |
| -429.9943% | |
| -179.5904% | |
| -19,587.6277% | |
| -44,261.6% | |
| -1,306.0965% |